Every material Form 8-K Healthcare Realty Trust filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Healthcare Realty reported third quarter 2026 results on October 29, 2026, with Normalized FFO of $0.42 per diluted share, up from $0.41 a year earlier, and a GAAP net loss of $(0.05) per share, narrower than the $(0.17) loss in the prior-year quarter. The company raised its full-year 2026 Normalized FFO guidance to $1.65-$1.67 per share from $1.62-$1.66 and raised its Same Store Cash NOI growth guidance to 5.00%-5.25%. Third quarter revenue fell to $286.6 million from $297.8 million a year earlier.
Q3 2026 Normalized FFO of $0.42 per diluted share, versus $0.41 in Q3 2025; NAREIT FFO of $0.38 versus $0.34
Q3 2026 GAAP net loss attributable to common stockholders of $15.8 million, or $(0.05) per share, versus $57.7 million, or $(0.17) per share, a year earlier
Full-year 2026 Normalized FFO guidance raised to $1.65-$1.67 per share from $1.62-$1.66 in July
Quarterly common dividend of $0.24 per share, payable November 20, 2026, to holders of record on November 10, 2026
Healthcare Realty reported second quarter 2026 total revenues of $281.8 million, down from $297.5 million a year earlier, and a GAAP net loss of $43.5 million, or $(0.13) per share, narrowed from $(0.45) a year earlier. Normalized FFO was $0.41 per share, flat with the prior-year quarter, and the company raised its full-year Normalized FFO guidance, but it lowered its full-year GAAP earnings per share guidance.
Q2 2026 total revenues were $281.8 million, versus $297.5 million in Q2 2025; GAAP net loss attributable to common stockholders was $43.5 million, or $(0.13) per share, versus $(0.45) per share a year earlier.
Normalized FFO was $0.41 per share, unchanged from Q2 2025; NAREIT FFO was $0.36 per share, up from $0.34.
2026 Normalized FFO guidance rose to $1.62 to $1.66 per share from $1.59 to $1.65; earnings per share guidance moved to $(0.15) to $(0.11) from $(0.05) to $0.05.
The board approved a $0.24 per share dividend payable August 26, 2026, to holders of record on August 11, 2026.
Healthcare Realty Trust and its operating partnership entered into a $400.0 million senior unsecured delayed draw term loan facility with Wells Fargo Bank as administrative agent, dated May 15, 2026. No borrowings were outstanding at closing, and the company can draw in up to three additional draws until the first anniversary of the closing date. The filing gives shareholders a committed source of borrowing with a scheduled maturity of May 15, 2029, and an accordion option for up to $100.0 million more.
Facility size: $400.0 million senior unsecured delayed draw term loan, with an accordion feature for up to an additional $100.0 million
Scheduled maturity: May 15, 2029; no borrowings outstanding as of the closing date
Agreement includes customary financial covenants, including leverage and coverage ratio requirements
Healthcare Realty Holdings, L.P., a subsidiary of Healthcare Realty Trust, issued $700 million of 3.00% exchangeable senior notes on May 7, 2026, including $100 million from the initial purchasers' full exercise of their option. The company fully and unconditionally guaranteed the notes, which are senior and unsecured, so the debt adds to the company's obligations for shareholders to consider.
Total principal of $700 million, including $100 million from the full exercise of the initial purchasers' option; notes mature January 15, 2032
Interest of 3.00% per year, paid semi-annually on January 15 and July 15, starting January 15, 2027
Initial exchange price of approximately $23.01 per share, equal to 43.4660 shares per $1,000 principal; the issuer may settle exchanges in cash or in cash and common stock
Company agreed to file a resale registration statement, with an effectiveness deadline of 180 days after the notes were first issued
Healthcare Realty Trust reported first quarter 2026 results on April 30, 2026. Normalized FFO was $0.41 per diluted share, up from $0.39 a year earlier, and the GAAP net loss narrowed to $56 thousand, or $(0.00) per share, from $44.9 million, or $(0.13) per share. Total revenues fell to $279.0 million from $299.0 million, and the company raised its 2026 Normalized FFO guidance to $1.59 to $1.65 per share.
Normalized FFO of $0.41 per diluted share, versus $0.39 in the first quarter of 2025; NAREIT FFO was $0.35 per share in both periods
GAAP net loss of $56 thousand, or $(0.00) per share, versus a net loss of $44.9 million, or $(0.13) per share, a year earlier
Total revenues of $279.0 million, versus $299.0 million in the first quarter of 2025
2026 Normalized FFO guidance raised to $1.59 to $1.65 per share from $1.58 to $1.64; quarterly dividend of $0.24 per share payable May 22, 2026
Healthcare Realty reported fourth quarter 2025 GAAP net income of $14.4 million, or $0.04 per share, compared with a net loss of $106.8 million a year earlier, and NAREIT FFO rose to $0.36 per share from $0.30. The company also issued 2026 guidance calling for Normalized FFO of $1.58 to $1.64 per share, roughly flat with $1.61 in 2025, and a $0.24 quarterly dividend.
Q4 2025 GAAP net income was $14.4 million ($0.04 per share) versus a net loss of $106.8 million ($0.31 per share) in Q4 2024.
Q4 2025 NAREIT FFO was $0.36 per share versus $0.30; Normalized FFO was $0.40 per share, unchanged from the prior year.
2026 guidance: Normalized FFO of $1.58 to $1.64 per share (2025: $1.61) and NAREIT FFO of $1.44 to $1.50 (2025: $1.38).
Dividend of $0.24 per share payable March 11, 2026, to holders of record on February 24, 2026; new commercial paper program of up to $600 million.
Healthcare Realty Trust appointed Daniel Gabbay, a former RBC Capital Markets managing director covering healthcare REITs, as executive vice president and chief financial officer effective January 12, 2026. CFO Austen Helfrich is leaving the same day, and the company expects to record a charge of approximately $5 million for the quarter ending March 31, 2026, related to his separation. The company said there is no change to its previously issued 2025 Normalized FFO guidance.
Daniel Gabbay becomes EVP and CFO effective January 12, 2026; he previously served as a managing director at RBC Capital Markets and Barclays.
Austen Helfrich, CFO since October 2024, departs effective January 12, 2026, under the termination other than for cause provisions of his employment agreement.
Gabbay's employment terms include a $500,000 base salary, a $625,000 target annual cash incentive, $1,375,000 in 2026 target equity awards, a $2,750,000 make-whole restricted stock award and $300,000 in relocation benefits.
The company expects a charge of approximately $5 million for the quarter ended March 31, 2026, tied to Helfrich's separation.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthcare Realty Trust filing is on SEC EDGAR ↗. 8-K briefs of other companies →